Penalty Amount
$300,000
Connecticut Attorney General William Tong announced a settlement with international trade platform Made-in-China to cease all U.S. sales of unlawful 'research grade' GLP-1 weight loss drugs following an investigation into direct sales to consumers without prescriptions or medical oversight. The settlement prohibits the platform from hosting GLP-1 sales to U.S. customers, requires a monitoring system to remove non-compliant listings, and imposes a $300,000 penalty suspended after an initial $30,000 payment. Additional settlements were announced with Radiance Medspa and Advanced Medical Weight Loss over compounded non-FDA approved GLP-1 drugs.
Made-in-China must prohibit manufacturers from advertising or selling GLP-1s to U.S. customers, deploy a monitoring system to detect and remove such listings, and remove existing GLP-1 listings within five days. The company is subject to a $300,000 penalty, with $30,000 due initially and the remaining $270,000 suspended; additional penalties apply for settlement violations.
In-house legal teams at online trade platforms and e-commerce vendors should review vendor agreements and terms of service to add explicit prohibitions on selling unapproved FDA-regulated drugs, prescription-only medications, and misbranded health products without valid medical oversight. Contracts should include requirements for automated monitoring systems to detect non-compliant listings, specified timeframes for removing prohibited content, and penalty clauses with suspended amounts that trigger upon breach of terms. Platforms should also include indemnification provisions and audit rights to ensure vendor compliance with health and safety regulations.
Entity
Made-in-China
Industry
Other"05/06/2026"
"Made-in-China"
"$300,000 penalty to the state, suspended after $30,000"
"violations of the Connecticut Unfair Trade Practices Act"
"unlawful sales of bootleg GLP-1 weight loss drugs direct to Connecticut consumers without prescriptions or any medical oversight"
"prohibits manufacturers from using the platform to advertise or sell GLP-1s to customers in the United States"
On May 11, 2026, Connecticut Attorney General William Tong led a bipartisan coalition of 21 attorneys general in submitting a comment letter to the U.S. Food and Drug Administration (FDA) urging the agency to abandon draft guidance that would ease approvals for flavored e-cigarette products. The coalition argues the guidance ignores evidence that flavored e-cigarettes disproportionately drive youth addiction and that FDA has failed to enforce existing authorization requirements for e-cigarette products. The letter references past tobacco and e-cigarette enforcement actions, including the 1998 tobacco master settlement agreement and the 2022 $438.5 million settlement with JUUL Labs.
Connecticut’s legislature passed House Bill 5312, creating new civil enforcement mechanisms for deepfake digital sexual assault, including unauthorized dissemination of synthetically created intimate images and AI-generated child pornography. The bill establishes a private right of action for victims and empowers the Connecticut Attorney General to pursue civil injunctions and penalties against abusers and platforms hosting illegal content. This builds on prior Connecticut laws criminalizing unauthorized intimate image dissemination.
Connecticut Attorney General William Tong praised final passage of House Bill 5312, which creates new civil enforcement mechanisms for deepfake digital sexual assault. The legislation allows the AG to pursue civil injunctions and penalties against platforms that disseminate illegal synthetic intimate images, including AI-generated child pornography, and establishes a private right of action for victims. The bill builds on prior Connecticut laws criminalizing unauthorized dissemination of intimate images.
Connecticut Attorney General William Tong issued a statement on May 1, 2026, announcing the final passage of bipartisan legislation targeting youth social media addiction and artificial intelligence harms. The legislation imposes new obligations on social media companies regarding minor account settings, parental consent, and reporting, as well as requirements for AI chatbot operators and employers using automated decision tools. The statement also references ongoing enforcement actions against Meta and TikTok for allegedly designing addictive platform features for youth.
Connecticut Attorney General William Tong issued a statement on May 1, 2026, following final passage of bipartisan legislation to combat youth social media addiction and regulate artificial intelligence harms. The legislation imposes new requirements on social media companies regarding minor users, including parental consent for addictive algorithms, default privacy settings, and annual reporting obligations. It also establishes rules for AI chat bots and automated employment decision tools, including disclosure requirements and self-harm detection protocols.
$7.4B
Connecticut Attorney General William Tong announced that Purdue Pharma will dissolve as the company’s bankruptcy concludes and a $7.4 billion settlement with Purdue and the Sackler family takes effect. The settlement permanently bars the Sacklers from selling opioids in the U.S., directs funds to addiction treatment and prevention, and requires the release of over 30 million documents related to Purdue’s opioid business. Connecticut is expected to receive $64 million from the settlement, with first payments anticipated in fall 2026.